Hanfeng Lin
ORCID: 0000-0002-3172-5616Also affiliated with Baylor School, NewGen Therapeutics (United States)
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 8 papers. Top paper: “Development of a RIPK1 degrader to enhance antitumor immunity”.
Dong Lu, Xiaoli Qi, Rishi R. Paudel, Hanfeng Lin, Bryan L. Holloman +8 more
Liya Hu, Hanfeng Lin, Allison Judge, Paola Rivera, Murugesan Palaniappan +5 more
Hanfeng Lin, Liya Hu, Neetu Neetu, Banumathi Sankaran, Jin Wang +3 more
Jianwei Chen, Xiqian Jiang, Dong Lu, Xin Yu, Hanfeng Lin +4 more
Hanfeng Lin, Bin Yang, Xiqian Jiang, Jianwei Chen, Sandipan Chowdhury +6 more
Bin Yang, Lang Ding, Yen‐Yu Yang, Matthew V. Holt, Sung Yun Jung +4 more
Wenhao Guo, Hanfeng Lin, Ran Cheng, Erika Y. Monroy, Feng Jin +6 more
Xin Qi Yu, Hanfeng Lin, Ran Cheng, Bin Yang, Min Zhang +5 more